4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

4 - CRH Medical Corp (0001461119) (Issuer)

15-12B - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

S-8 POS - CRH Medical Corp (0001461119) (Filer)

8-K - CRH Medical Corp (0001461119) (Filer)

25-NSE - CRH Medical Corp (0001461119) (Subject)

Canaccord Genuity downgraded CRH Medical from Buy to Hold and set a new price target of $4.00

RBC Capital Mkts downgraded CRH Medical from Outperform to Sector Perform

CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021. The transaction is expected to be completed on or about April 22, 2021 and represents WELL's largest acquisition to date with a total transaction value of approximately US$369.2 million. Upon closing, subscription receipts from WELL's previously announced C$302.5M equity offering will be exchanged into common shares of WELL. VANCOUVER, BC, April 19, 2021 /CNW/ - WELL Health Technologies Corp. (TSX:WELL) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within the heal

CRH Medical Corp.'s securityholders approved the acquisition of CRH by a subsidiary of WELL Health at the special meeting of CRH securityholders on Friday April 16, 2021. The transaction is expected to be completed on or about April 22, 2021 and represents WELL's largest acquisition to date with a total transaction value of approximately US$369.2 million. Upon closing, subscription receipts from WELL's previously announced C$302.5M equity offering will be exchanged into common shares of WELL. VANCOUVER, BC, April 19, 2021 /PRNewswire/ - WELL Health Technologies Corp. (TSX:WELL) ("WELL" or the "Company"), a company focused on consolidating and modernizing clinical and digital assets within t

VANCOUVER, BC, April 16, 2021 /CNW/ - CRH Medical Corporation (TSX:CRH) (NYSE:CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today. The special resolution approving the arrangement was approved by: (i) 97.30% of the votes cast by CRH shareholders present in person or represented by proxy at the meeting; (ii) 97.49% of the votes cast by CRH shareholders, share unitholders and optionholders voting as a single class present in person or represented by proxy at the meeting; and (iii) 97.27% of the votes cast by "minority" CRH sh

VANCOUVER, BC, April 16, 2021 /PRNewswire/ - CRH Medical Corporation (TSX:CRH) (NYSE:CRHM) ("CRH" or the "Company") today announced that its securityholders approved the acquisition of CRH by a subsidiary of WELL Health Technologies Corp. ("WELL Health") at the special meeting of CRH securityholders today. The special resolution approving the arrangement was approved by: (i) 97.30% of the votes cast by CRH shareholders present in person or represented by proxy at the meeting; (ii) 97.49% of the votes cast by CRH shareholders, share unitholders and optionholders voting as a single class present in person or represented by proxy at the meeting; and (iii) 97.27% of the votes cast by "minority"

VANCOUVER, BC, April 7, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE American: CRHM) ("CRH" or the "Company") announced today that it has filed with the U.S. Securities and Exchange Commission (the "SEC") a Current Report on Form 8-K containing certain disclosures that are intended to amend and supplement the Company's proxy statement and management information circular, dated March 19, 2021 (the "Circular"), relating to the special meeting of CRH securityholders that will be held in connection with the proposed acquisition of CRH by WELL Health Technologies Corp. (the "Arrangement"), which Circular was previously mailed to securityholders. The Current Report and supplemental

VANCOUVER, BC, April 5, 2021 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has completed an accretive transaction whereby the Company has acquired the remaining 25% interest in Lake Lanier Anesthesia Associates ("LLAA") a gastroenterology anesthesia practice located in Georgia. CRH initially acquired 75% of LLAA in June of 2020.This transaction will increase adjusted operating EBITDA attributable to shareholders, as CRH now owns 100% of LLAA. This transaction was financed through a combination of CRH's credit facility and cash on hand. Jay Kreger, President of CRH Anesthesia, added, "Our initial partnership with LLAA has proven

VANCOUVER, BC, April 1, 2021 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it completed an accretive transaction whereby the Company has acquired a 51% interest in Middle Arkansas Sedation Associates, LLC ("MASA"), a gastroenterology anesthesia practice located in Little Rock, Arkansas. MASA represents the Company's 33rd acquisition, and provides anesthesia services to a single ambulatory surgery center. The transaction was financed through a combination of CRH's credit facility and cash on hand. Financial Highlights: Estimated annual revenue of US $1.4 million Operating EBITDA margin of approximately 50% Cash flow accretive D

VANCOUVER, BC, March 25, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE American: CRHM) ("CRH" or the "Company") announced today that it has mailed materials to the shareholders (the "Shareholders") optionholders and share unit holders of CRH, including the proxy statement and management information circular of the Company dated March 19, 2021 (the "Circular"), for the special meeting of CRH securityholders (the "Meeting") to be held on April 16, 2021 in connection with the proposed acquisition by WELL Health Technologies Corp. ("WELL") of all of the issued and outstanding common shares of the Company ("CRH Shares") pursuant to a plan of arrangement to be approved by the Suprem

VANCOUVER, BC, March 16, 2021 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) ("CRH" or the "Company"), today announced financial and operating results for the year and three months ended December 31, 2020. Fourth quarter 2020 highlights (all results expressed in USD): Total revenue of $36.8 million, an increase of 21% from fourth quarter 2019 Anesthesia services revenue of $34.1 million, an increase of 24% from fourth quarter 2019 Anesthesia patient cases of 108,681 increased 15% from fourth quarter 2019 Adjusted operating EBITDA of $16.1 million, a 44% adjusted operating EBITDA margin Adjusted operating shareholder EBITDA of $11.2 million, an increase of 27% from fo

VANCOUVER, BC, March 11, 2021 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) today announces a startup joint venture ("JV") where CRH owns a 51% interest in a gastroenterology anesthesia practice located in Largo, Florida. The JV services a single ambulatory surgery center ("ASC"). CRH and its partners will contribute this entity into its existing JV with FDHS Anesthesia, LLC. Financial Highlights: Estimated annual revenue of US $1.7 million EBITDA and cash flow accretive Dr. Tushar Ramani, CEO of CRH, commented on the JV, "We now provide services to 71 ambulatory surgery centers across 14 states, and we see ample opportunity for additional bu

VANCOUVER, BC, Dec. 22, 2020 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM) announces that it has received notice today that its largest customer, United Digestive ("UD"), does not intend to renew its professional services agreements pursuant to which CRH provides anesthesia services to 12 of UD's surgery centers in the Greater Atlanta Georgia market. UD represents a significant portion of CRH's revenue, and is expected to represent approximately 20% of adjusted operating shareholder EBITDA ("EBITDA") in 2021. The current professional services agreements are scheduled to expire on October 31, 2021, meaning that the non-renewal will become effe

VANCOUVER, BC, Dec. 14, 2020 /PRNewswire/ - CRH Medical Corporation ("CRH", or the "Company") (TSX: CRH) (NYSE MKT: CRHM), announces that it completed an accretive transaction whereby the Company has acquired a 51% interest in FDHS Anesthesia, LLC ("FDHS"), a gastroenterology anesthesia practice located in Sarasota, Florida. FDHS represents the Company's 31st acquisition, and provides anesthesia services to two ambulatory surgery centers located in Florida. The transaction was financed through a combination of CRH's credit facility and cash on hand. FDHS Transaction Highlights: Estimated annual revenue of US $3.0 million EBITDA and cash flow accretive Dr. Tushar Ramani, CEO of CRH, com

SC 13D - CRH Medical Corp (0001461119) (Subject)

SC 13G/A - CRH Medical Corp (0001461119) (Subject)

SC 13G/A - CRH Medical Corp (0001461119) (Subject)